Alpine Global Management’s Immunome IMNM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-51,178
| Closed | -$619K | – | 292 |
|
|
2024
Q2 | $619K | Sell |
51,178
-91,119
| -64% | -$1.1M | 0.11% | 158 |
|
|
2024
Q1 | $3.51M | Sell |
142,297
-50,036
| -26% | -$1.23M | 0.68% | 29 |
|
|
2023
Q4 | $2.06M | Sell |
192,333
-173,638
| -47% | -$1.86M | 0.56% | 39 |
|
|
2023
Q3 | $3.06M | Hold |
365,971
| – | – | 0.7% | 22 |
|
|
2023
Q2 | $2.89M | Hold |
365,971
| – | – | 0.8% | 27 |
|
|
2023
Q1 | $1.83M | Sell |
365,971
-352,264
| -49% | -$1.76M | 0.71% | 25 |
|
|
2022
Q4 | $1.58M | Hold |
718,235
| – | – | 0.53% | 25 |
|
|
2022
Q3 | $3.19M | Hold |
718,235
| – | – | 0.75% | 30 |
|
|
2022
Q2 | $2.31M | Sell |
718,235
-159,000
| -18% | -$510K | 0.58% | 41 |
|
|
2022
Q1 | $5.09K | Buy |
877,235
+15,064
| +2% | +$87 | 1.15% | 18 |
|
|
2021
Q4 | $11.2M | Buy |
862,171
+7,500
| +0.9% | +$97.2K | 1.64% | 6 |
|
|
2021
Q3 | $20.8M | Hold |
854,671
| – | – | 4.72% | 3 |
|
|
2021
Q2 | $14.8M | Buy |
854,671
+58,962
| +7% | +$1.02M | 2.01% | 15 |
|
|
2021
Q1 | $27M | Buy |
795,709
+5,501
| +0.7% | +$186K | 2.58% | 10 |
|
|
2020
Q4 | $7.65M | Buy |
+790,208
| New | +$7.65M | 1.55% | 15 |
|